Skip to main content

Advertisement

Fig. 4 | BMC Cancer

Fig. 4

From: FAM168A participates in the development of chronic myeloid leukemia via BCR-ABL1/AKT1/NFκB pathway

Fig. 4

FAM168A interacts with BCR-ABL1 and AKT1. K562 cells were seeded in a 10 cm dish. Cells were harvested and lysed with RIPA buffer. a The lysates were incubated with normal mouse IgG-conjugated agarose (Ig G), anti-FAM168A antibody-conjugated agarose (FAM168A) or anti-ABL1 antibody-conjugated agarose (ABL1). The immunoprecipitants and cell lysates (Input) were electrophoresed and immunoblotted with ABL1 and FAM168A. b The K562 lysates were incubated with normal mouse IgG-conjugated agarose (Ig G), anti-FAM168A antibody-conjugated agarose (FAM168A) or anti-AKT1 antibody-conjugated agarose (AKT1). The immunoprecipitants and cell lysates (Input) were electrophoresed and immunoblotted with AKT1 and FAM168A

Back to article page